Rhon-klinikum Ag · XETR:RHK
Rhon-klinikum — Non-Deal Roadshow (April 2013)
14 slides from Rhon-klinikum's roadshow presentation, Apr 25, 2013
Slide 1: RHÖN-KLINIKUM AG Roadshow Presentation
RHÖN-KLINIKUM AG Roadshow Presentation
Slide 2: RHÖN-KLINIKUM at a Glance
RHÖN-KLINIKUM at a Glance Germany’s only listed acute care hospital operator Resilient and non-cyclical business model Leading market position and proven growth story Operation of 54 hospitals in 10 federal states More than 2.55 million cases treated in 2012 with and 41 outpatient centers (MVZs) app
Slide 3: Sustainable Organic Growth Augmented by Potential for Further External Growth
Sustainable Organic Growth Augmented by Potential for Further External Growth Group revenue has almost tripled since 2004 to approx. € 2.865 bn in 2012 Changing demographic patterns and progress of medical million € CAGR: + 13% (organic: + 4%) technology imply continued increase in demand and 3000 2
Slide 4: 2012 Full-Year Results and 2013 First Quarter Results
RHÖN-KLINIKUM AG 2012 Full-Year Results and 2013 First Quarter Results April 25, 2013 Jens-Peter Neumann, CFO of RHÖN-KLINIKUM AG
Slide 5: FY 2012: Impacts of an Event-Driven Year
FY 2012: Impacts of an Event-Driven Year Revenues (m€) EBITDA (m€) and EBITDA margin 3,000 CAGR 7.7% 2,865 338 307 291 2,750 284 263 2,629 2,550 2,500 2,320 12.3% 12.2% 12.0% 12.8% 10.2% 2,250 2,130 2,000 2008 2009 2010 2011 2012 2008 2009 2010 2011* 2012 * FY 2011 EBITDA adjusted for ending particl
Slide 6: FY 2012: P&L Key Figures
FY 2012: P&L Key Figures Performance FY 2012 includes first-time consolidation FY 2012 vs. FY 2011 in million € effects of HSK Wiesbaden and new MVZs Revenue 2,865 100.0% +9.0% Organic revenue growth: +2.9% Personnel expenses -1,741 60.8% +11.4% Organic increase of personnel expenses +4.6% and of ma
Slide 7: Dividend Proposal
Dividend Proposal Board of Management and Supervisory Board will propose to the AGM to distribute a dividend of € 0.25 per share Payout ratio maintained (approx. 38.5%) based on an EPS of € 0.65 Total dividend sum: € 34.6m RHÖN-KLINIKUM AG - 2012 Full-Year Results and 2013 First Quarter Results - as
Slide 8: Q1 2013: On-Track To Reach Full-Year Targets
Q1 2013: On-Track To Reach Full-Year Targets Group Revenues Q1 2013 (in million €) 800 800 +10.2% 750 770 752.2 +11.9 +58.0 (+1.7%) 752.2 700 (+8.5%) 740 742.4 682.3 732.2 650 710 708.0 600 680 682.3 550 650 Revenues External growth Internal growth Revenues Q1 Q2 Q3 Q4 Q1 2012 Q1 2013 Revenues FY 20
Slide 9: Q1 2013: P&L Key Figures
Q1 2013: P&L Key Figures Performance Q1 2013 vs. Q1 2012 in million € Revenue 752.2 100.0% +10.2% Q1 2013 also includes first-time consolidation effects of HSK and new MVZs Personnel expenses - 459.7 61.1% +12.6% Result of wage negotiations in H2 2012 and impact of HSK consolidation with cost ratios
Slide 10: Core Balance Sheet Figures as of 31.03.2013
Core Balance Sheet Figures as of 31.03.2013 €3,185m €3,185 m Solid balance structure, € 1,635m but slightly increasing leverage 51.3% € 2,365m Equity in Q1 driven by 74.3% Non-current assets Higher debt, mainly due to € 808m HSK acquisition 25.4% Long-term debt EBITDA setbacks in 2012 € 820m € 743m
Slide 11: Outlook 2013
Outlook 2013 Key Levers Pricing 2013: Close to 2.0%, thus in line with expectations for FY 2013 Typical seasonality due to negotiation of budget volumes and discounts on agreed- upon additional volumes on the individual hospital level Supplementary federal financing program for hospital sector curre
Slide 12: Appendix - Shareholders
Appendix - Shareholders Shareholder structure of RHÖN-KLINIKUM AG as of December 31, 2012 (according to the most recent notifications of voting rights at that time) Münch Family 12.5% Alecta pensionsförsäkring ömesesidigt 9.9% Asklepios / Dr. gr. Broermann 5.0% B. Braun Melsungen 5.0% Else Kröner-Fr
Slide 13: Financial Calendar 2013
Financial Calendar 2013 February 21, 2013 Preliminary annual results for fiscal year 2012 April 25, 2013 Press conference: Publication of 2012 annual financial report Publication of interim report for the quarter ending March 31, 2013 June 12, 2013 Annual General Meeting (Jahrhunderthalle Frankfurt)
Slide 14: Disclaimer
Disclaimer • This document has been prepared by RHÖN-KLINIKUM AG (“RHÖN-KLINIKUM” or “the Company”) for information purposes only, solely for the use at this presentation and must be treated confidentially by attendees at such presentation and must not be distributed, passed on or otherwise disclose